Physician profile
Jamie E Tigner
NPI 1568766251
$2,743.00
in general payments reported to CMS, 2019-2025
13 companies · $794 in 2025
The $794 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $269 · 2022: $319 · 2023: $743 · 2024: $617 · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,984 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,984.45 |
| Education | $170.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,167.86 | 2022-2025 | |
| Janssen Biotech, INC. | $802.17 | 2021-2025 | Stelara, Tremfya |
| Lilly USA, LLC | $218.79 | 2024-2025 | Omvoh |
| Intercept Pharmaceuticals, INC. | $120.76 | 2021-2023 | Ocaliva |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.43 | 2021-2025 | Xifaxan, Plenvu |
| E.R. Squibb & Sons, L.L.C. | $87.81 | 2023-2024 | Sotyktu |
| Nestle Healthcare Nutrition INC. | $71.57 | 2021-2022 | |
| Pfizer INC. | $37.98 | 2025 | |
| Genzyme Corporation | $34.26 | 2025 | |
| Aimmune Therapeutics, INC. | $32.38 | 2025 | Zenpep |
| Celgene Corporation | $31.45 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.30 | 2021 | |
| Janssen Pharmaceuticals, INC | $9.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Tigner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.